266 related articles for article (PubMed ID: 32128294)
21. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
Love LA; Leff RL; Fraser DD; Targoff IN; Dalakas M; Plotz PH; Miller FW
Medicine (Baltimore); 1991 Nov; 70(6):360-74. PubMed ID: 1659647
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
Ernste FC; Reed AM
Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
[TBL] [Abstract][Full Text] [Related]
23. Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon.
Patwardhan A; Spencer CH
Pediatr Rheumatol Online J; 2019 Aug; 17(1):56. PubMed ID: 31429786
[TBL] [Abstract][Full Text] [Related]
24. Utilization of myositis antibody-specific panel for diagnosis, treatment, and evaluation of disease progression.
Stark A; Hauptman H; Nguyen B; Mathew M; Aversano A; Mueller J
J Community Hosp Intern Med Perspect; 2020 Sep; 10(5):462-465. PubMed ID: 33235684
[TBL] [Abstract][Full Text] [Related]
25. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
26. The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease.
Huang HL; Lin WC; Lin PY; Weng MY; Sun YT
Neurol Sci; 2021 Jul; 42(7):2855-2864. PubMed ID: 33211209
[TBL] [Abstract][Full Text] [Related]
27. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
28. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
[TBL] [Abstract][Full Text] [Related]
29. The spectrum of idiopathic inflammatory myopathies in South Africa.
Chinniah KJ; Mody GM
Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
[TBL] [Abstract][Full Text] [Related]
30. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.
Shamim EA; Rider LG; Pandey JP; O'Hanlon TP; Jara LJ; Samayoa EA; Burgos-Vargas R; Vazquez-Mellado J; Alcocer-Varela J; Salazar-Paramo M; Kutzbach AG; Malley JD; Targoff IN; Garcia-De la Torre I; Miller FW
Arthritis Rheum; 2002 Jul; 46(7):1885-93. PubMed ID: 12124873
[TBL] [Abstract][Full Text] [Related]
31. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
32. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy.
Rider LG; Gurley RC; Pandey JP; Garcia de la Torre I; Kalovidouris AE; O'Hanlon TP; Love LA; Hennekam RC; Baumbach LL; Neville HE; Garcia CA; Klingman J; Gibbs M; Weisman MH; Targoff IN; Miller FW
Arthritis Rheum; 1998 Apr; 41(4):710-9. PubMed ID: 9550481
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte immunophenotyping in inflammatory myositis: a review.
Franco C; Gatto M; Iaccarino L; Ghirardello A; Doria A
Curr Opin Rheumatol; 2021 Nov; 33(6):522-528. PubMed ID: 34402455
[TBL] [Abstract][Full Text] [Related]
34. Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity.
Zhao L; Su K; Liu T; Sun D; Jiang Z
Clin Rheumatol; 2021 Mar; 40(3):1009-1016. PubMed ID: 32676923
[TBL] [Abstract][Full Text] [Related]
35. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
36. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
37. Idiopathic inflammatory myopathies.
Lundberg IE; Fujimoto M; Vencovsky J; Aggarwal R; Holmqvist M; Christopher-Stine L; Mammen AL; Miller FW
Nat Rev Dis Primers; 2021 Dec; 7(1):86. PubMed ID: 34857798
[TBL] [Abstract][Full Text] [Related]
38. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
Rider LG; Katz JD; Jones OY
Rheum Dis Clin North Am; 2013 Nov; 39(4):877-904. PubMed ID: 24182859
[TBL] [Abstract][Full Text] [Related]
39. Classification of idiopathic inflammatory myopathies: pathology perspectives.
Tanboon J; Nishino I
Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.
Pagnini I; Vitale A; Selmi C; Cimaz R; Cantarini L
Clin Rev Allergy Immunol; 2017 Feb; 52(1):34-44. PubMed ID: 26429707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]